✦ LIBER ✦

Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers

✍ Scribed by Karen T. Hallam; James S. Olver; Caroline McGrath; Trevor R. Norman

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 74 KB
Volume: 18
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.542

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Objectives

To assess the cognitive and psychomotor effects of single oral doses of valerian in healthy volunteers in comparison with a placebo and the hypnotic agent triazolam.

Methods

In a double‐blind, placebo‐controlled, four‐way crossover study nine healthy subjects (5 males, 4 females) received in random order valerian 500 mg, valerian 1000 mg, triazolam 0.25 mg and placebo. Doses were separated by a wash‐out period of at least 1 week. Subjects were tested before each dose and at 2, 4 and 8 h after the dose of each compound using the critical flicker fusion (CFF), choice reaction time (CRT), digit symbol substitution test (DSST), symbol search test (SST), digit span test (DST) and visual analogue scales of mood.

Results

Repeated measures ANOVA was used to examine the changes in performance on tests over time and significant effects were further analysed using simple main effects analysis with least significant difference corrections. Statistically significant differences were only noted for the cognitive tests: SST (F~(3, 8)~=3.182, p<0.05) and DSST (F~(3, 8)~=9.688, p<0.005). In both cases the differences between groups were due to the effects of triazolam.

Conclusion

These data confirm that at recommended therapeutic doses, triazolam has detrimental effects on cognitive processes in healthy volunteers as found in previous studies. Valerian was without effect on either cognitive or psychomotor performance in healthy volunteers at the doses used in this study. Should the hypnotic activity of valerian be confirmed in randomized double‐blind trials it may be a less troublesome alternative to benzodiazepines in the treatment of insomnia. Copyright © 2003 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Comparative study of acute effects of si

Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers

✍ Hiroyuki Kamei; Yukihiro Noda; Kazuhiro Ishikawa; Koji Senzaki; Isao Muraoka; Yo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract Since most classical (first‐generation) antihistamines have undesirable sedative effects on the central nervous system (CNS), newer (second‐generation) antihistamines have been developed to relieve the sedative effects and to improve the patient's quality of life. However, the psychomot

Dose-effect study of levomepromazine on

Dose-effect study of levomepromazine on psychomotor and memory tasks in healthy volunteers

✍ D. Warot; M. O. Krebs; G. Bensimon; C. Payan; Ph. Danjou; L. Lacomblez; A. J. Pu 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 1 views

The effects of single doses of levomepromazine (3,6 and 12mg) on psychomotor skills and memory tasks, as well as haemodynamic and pupil diameter parameters, were assessed in 12 normal volunteers. Each subject was given three of the four treatments, at a weekly interval in a double-blind crossover ra

Single dose pharmacokinetics and bioavai

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

✍ Michael J. Lamson; John P. Sabo; Thomas R. Macgregor; Joseph W. Pav; Lois Rowlan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.

Effects of nocturnal doses of mirtazapin

Effects of nocturnal doses of mirtazapine and mianserin on sleep and on daytime psychomotor and driving performance in young, healthy volunteers

✍ J. G. Ramaekers; N. D. Muntjewerff; L. M. A. Van Veggel; M. M. C. Uiterwijk; J. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Eighteen healthy volunteers participated in a randomized, double blind, cross-over trial. They received mirtazapine, mianserin or placebo during separate periods of 15 days. Mirtazapine and mianserin were respectively administered in doses of 15 mg and 30 mg nocte for the ®rst 7 days and doses of 30

Single-dose bioavailability of oral and

Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers

✍ P. Sandouk; M. Bouvier d'Yvoire; P. Chretien; J. P. Tillement; J. M. Scherrmann 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

A single dose of 8 mg of thiocolchicoside was administered to 12 healthy volunteers according to a Latin square design, either as tablets (reference), oral solution, or intramuscular injection. Serum thiocolchicoside concentrations showed an absorption phase followed by a biexponential decay with a

Effects of single and multiple doses of

Effects of single and multiple doses of dexnafenodone, imipramine and placebo on sleep of young healthy volunteers

✍ H. Schulz; U. Legler; M. Jobert; G. Greger 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

The effects on polygraphically recorded sleep of single and repeated doses of dexnafenodone (20 mg daily) were determined in 12 young, healthy subjects, and compared to those of imipramine (75 mg daily: six subjects) and placebo (six subjects). After two adaptation nights, sleep was recorded at base